Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)

Renal cell carcinoma (RCC) is one of the most lethal genitourinary malignancies. Recently, there has been a paradigm shift in the management of advanced RCC. New targeted therapies including vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) inhibitors have been devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahani, Rohan, Kwan, Kevin G, Kapoor, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108692/
https://www.ncbi.nlm.nih.gov/pubmed/21701620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108692/
https://www.ncbi.nlm.nih.gov/pubmed/21701620

Ejemplares similares